ctrl K

AN2 Therapeutics Inc. (ANTX)

NASDAQ: ANTX · Real-Time Price · USD

1.22

-0.02 (-1.61%)

At close: May 02, 2025, 3:59 PM

1.22

0.41%

After-hours: May 02, 2025, 04:05 PM EDT

AN2 Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	77K	n/a	n/a	n/a
Gross Profit	n/a	n/a	-77K	n/a	n/a	n/a
Operating Income	-54.55M	-69.64M	-42.26M	-21.57M	-7.28M	-5.18M
Interest Income	5.47M	n/a	1.35M	69K	3K	n/a
Pretax Income	-51.32M	-64.73M	-40.96M	-21.54M	-13.6M	-5.63M
Net Income	-51.32M	-64.73M	-41.47M	-21.47M	-13.6M	-5.63M
Selling & General & Admin	14.07M	14.76M	12.75M	4.67M	1.26M	289K
Research & Development	40.49M	54.87M	29.51M	16.91M	6.02M	4.89M
Other Expenses	n/a	n/a	-45K	-38K	-6.32M	n/a
Operating Expenses	54.55M	69.64M	42.26M	21.57M	7.28M	5.18M
Interest Expense	n/a	n/a	514K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	287.27K
Cost & Expenses	-54.55M	69.64M	42.26M	21.57M	7.28M	5.18M
Income Tax Expense	n/a	n/a	514K	-69K	-3K	-31.07K
Shares Outstanding (Basic)	29.83M	23.6M	19.4M	18.74M	18.74M	18.74M
Shares Outstanding (Diluted)	29.83M	23.6M	19.4M	18.74M	18.74M	18.74M
EPS (Basic)	-1.72	-2.74	-2.14	-1.15	-0.73	-0.3
EPS (Diluted)	-1.72	-2.74	-2.14	-1.15	-0.73	-0.3
EBITDA	-51.32M	4.9M	-42.26M	n/a	-6.32M	n/a
EBIT	-51.32M	-64.73M	-40.96M	-21.54M	-13.6M	-31.07M
Depreciation & Amortization	n/a	69.64M	77K	21.57M	7.28M	31.07M